- A Georgia Primary Care Clinic is now using an autonomous AI system called IDx-DR to test patients for diabetic retinopathy, a leading cause of blindness.
- IDx-DR is cleared by the FDA to make an assessment without the need for a clinician to also interpret the image or results, making it usable by healthcare providers who may not normally be involved in eye care.
- The exam typically takes 5-10 minutes. Nurses use an automated fundus camera to take pictures of the patient’s retinas –
Read More
CB Insights Unveils ‘Digital Health 150’ List of Startups Transforming Healthcare
- CB Insights unveils first-ever annual ‘Digital Health 150’ list of digital health startups working to transform the healthcare industry.
- The Digital Health 150 companies span a wide spectrum of categories that involve all three key stakeholder groups for the healthcare industry — providers, payers, and patients.
- A total of 17 companies on the list are unicorns (private companies valued at $1B+). Of these, 12 companies are US-based, 3 are based in China, 1 is based in France, and 1
Read More
Bill Conway Returns to athenahealth as Chief Sales Officer
athenahealth, Inc., a provider of network-enabled services for ambulatory and hospital customers nationwide, announced today that Bill Conway has been appointed Chief Sales Officer. In his new role, Mr. Conway will work closely with the athenahealth executive leadership team on strategic execution to help accelerate the Company’s vision of transforming the healthcare industry. Bill Conway, a health IT industry veteran previously served as Senior Vice President of Sales and Client Services at
Read More
IDx and Topcon Join Forces to Scale AI-based Diagnostic Platform in the U.S. Market
IDx, an AI diagnostics company, and Topcon, one of the world’s leading ophthalmic device manufacturers, have signed an exclusivity agreement that will allow the companies to scale delivery of AI-based diagnostic solutions in the U.S. market. As part of the agreement, is granted exclusive rights to IDx-DR system, an autonomous AI system that instantly detects diabetic retinopathy in fundus images, exclusively with Topcon NW400, an easy to use, robotic fundus camera. IDx-DR is an FDA-cleared
Read More
AI Diagnostics Startup IDx Nabs $33M for Autonomous Detection of Diabetic Retinopath
IDx, a Coralville, Iowa-based startup that developed the first and only FDA-cleared autonomous AI diagnostic systems, has raised $33 million in funding led by 8VC with participation from Optum Ventures, Alpha Edison and Heritage Provider Network. This latest round of funding will accelerate the adoption of IDx-DR and allow IDx to continue developing additional AI-based diagnostic systems.Founded in 2010 by a team of clinical scientists, IDx is focused on developing clinically-aligned autonomous
Read More